LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 54

Suchoptionen

  1. Artikel ; Online: Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk, early breast cancer - Authors' reply.

    Johnston, Stephen R D / André, Valérie

    The Lancet. Oncology

    2022  Band 24, Heft 3, Seite(n) e104

    Mesh-Begriff(e) Humans ; Female ; Breast Neoplasms ; Aminopyridines ; Benzimidazoles ; Immunologic Factors
    Chemische Substanzen abemaciclib (60UAB198HK) ; Aminopyridines ; Benzimidazoles ; Immunologic Factors
    Sprache Englisch
    Erscheinungsdatum 2022-11-08
    Erscheinungsland England
    Dokumenttyp Letter ; Comment
    ZDB-ID 2049730-1
    ISSN 1474-5488 ; 1470-2045
    ISSN (online) 1474-5488
    ISSN 1470-2045
    DOI 10.1016/S1470-2045(23)00065-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Buch: Dictionnaire des femmes des Lumières

    André, Valérie / Krief, Huguette

    (Dictionnaires références ; ...)

    2015  

    Verfasserangabe sous la dir. de Huguette Krief et Valérie André. Avec une introd. de Huguette Krief
    Serientitel Dictionnaires références
    ...
    Sprache Französisch
    Verlag Champion
    Erscheinungsort Paris
    Dokumenttyp Buch
    ISBN 9782745324870 ; 274532487X
    Datenquelle Ehemaliges Sondersammelgebiet Küsten- und Hochseefischerei

    Zusatzmaterialien

    Kategorien

  3. Buch: Dictionnaire des femmes des Lumières

    André, Valérie / Krief, Huguette

    (Dictionnaires & références ; 25,[1])

    2015  

    Verfasserangabe sous la dir. de Huguette Krief et Valérie André; avec une introd. de Huguette Krief
    Serientitel Dictionnaires & références ; 25,[1]
    Sprache Französisch
    Umfang 650 S.
    Verlag Champion
    Erscheinungsort Paris
    Dokumenttyp Buch
    Datenquelle Ehemaliges Sondersammelgebiet Küsten- und Hochseefischerei

    Zusatzmaterialien

    Kategorien

  4. Buch: Dictionnaire des femmes des Lumières

    André, Valérie / Krief, Huguette

    (Dictionnaires références ; 25,[2])

    2015  

    Verfasserangabe sous la dir. de Huguette Krief et Valérie André; avec une introd. de Huguette Krief
    Serientitel Dictionnaires références ; 25,[2]
    Sprache Französisch
    Umfang S. 652 - 1337
    Verlag Champion
    Erscheinungsort Paris
    Dokumenttyp Buch
    Datenquelle Ehemaliges Sondersammelgebiet Küsten- und Hochseefischerei

    Zusatzmaterialien

    Kategorien

  5. Artikel: Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage

    Souak, Djouhar / Barreau, Magalie / Courtois, Aurélie / André, Valérie / Duclairoir Poc, Cécile / Feuilloley, Marc G. J / Gault, Manon

    Microorganisms. 2021 Apr. 27, v. 9, no. 5

    2021  

    Abstract: Many studies performed in the last decade have focused on the cutaneous microbiota. It has been shown that this microbiota plays a key role in skin homeostasis. Considered as “a second barrier” to the environment, it is very important to know how it ... ...

    Abstract Many studies performed in the last decade have focused on the cutaneous microbiota. It has been shown that this microbiota plays a key role in skin homeostasis. Considered as “a second barrier” to the environment, it is very important to know how it reacts to exogenous aggressions. The cosmetics industry has a started to use this microbiota as a source of natural ingredients, particularly ones that confer photoprotection against ultraviolet (UV) rays. Interestingly, it has been demonstrated that bacterial molecules can block UV rays or reverse their harmful effects. Oral probiotics containing living microorganisms have also shown promising results in restoring skin homeostasis and reversing the negative effects of UV rays. Microbial-based active sunscreen compounds have huge potential for use as next-generation photoprotection products.
    Schlagwörter homeostasis ; industry ; probiotics ; radiation resistance ; sunscreens
    Sprache Englisch
    Erscheinungsverlauf 2021-0427
    Erscheinungsort Multidisciplinary Digital Publishing Institute
    Dokumenttyp Artikel
    Anmerkung NAL-AP-2-clean
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms9050936
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  6. Artikel: Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.

    Goetz, Matthew P / Cicin, Irfan / Testa, Laura / Tolaney, Sara M / Huober, Jens / Guarneri, Valentina / Johnston, Stephen R D / Martin, Miguel / Rastogi, Priya / Harbeck, Nadia / Shahir, Ashwin / Wei, Ran / André, Valérie / Rugo, Hope S / O'Shaughnessy, Joyce

    NPJ breast cancer

    2024  Band 10, Heft 1, Seite(n) 34

    Abstract: In monarchE, adjuvant abemaciclib significantly improved invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), with sustained benefit beyond the 2-year treatment period. Abemaciclib dose reductions were allowed to proactively ... ...

    Abstract In monarchE, adjuvant abemaciclib significantly improved invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), with sustained benefit beyond the 2-year treatment period. Abemaciclib dose reductions were allowed to proactively manage adverse events. Exploratory analyses to investigate the impact of dose reductions on efficacy were conducted. Across the three patient subgroups as defined by relative dose intensity (≤66%, 66-93%, ≥93%), the estimated 4-year IDFS rates were generally consistent (87.1%, 86.4%, and 83.7%, respectively). In the time-dependent Cox proportional hazard model, the effect of abemaciclib was consistent at the full dose compared to being reduced to a lower dose (IDFS hazard ratio: 0.905; 95% confidence interval: 0.727, 1.125; DRFS hazard ratio: 0.942; 95% confidence interval: 0.742, 1.195). These analyses showed that the efficacy of adjuvant abemaciclib was not compromised by protocol mandated dose reductions for patients with node positive, hormone receptor positive, human epidermal growth factor 2-negative, high-risk early breast cancer.
    Sprache Englisch
    Erscheinungsdatum 2024-04-26
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ISSN 2374-4677
    ISSN 2374-4677
    DOI 10.1038/s41523-024-00639-1
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Challenging Cosmetic Innovation: The Skin Microbiota and Probiotics Protect the Skin from UV-Induced Damage.

    Souak, Djouhar / Barreau, Magalie / Courtois, Aurélie / André, Valérie / Duclairoir Poc, Cécile / Feuilloley, Marc G J / Gault, Manon

    Microorganisms

    2021  Band 9, Heft 5

    Abstract: Many studies performed in the last decade have focused on the cutaneous microbiota. It has been shown that this microbiota plays a key role in skin homeostasis. Considered as "a second barrier" to the environment, it is very important to know how it ... ...

    Abstract Many studies performed in the last decade have focused on the cutaneous microbiota. It has been shown that this microbiota plays a key role in skin homeostasis. Considered as "a second barrier" to the environment, it is very important to know how it reacts to exogenous aggressions. The cosmetics industry has a started to use this microbiota as a source of natural ingredients, particularly ones that confer photoprotection against ultraviolet (UV) rays. Interestingly, it has been demonstrated that bacterial molecules can block UV rays or reverse their harmful effects. Oral probiotics containing living microorganisms have also shown promising results in restoring skin homeostasis and reversing the negative effects of UV rays. Microbial-based active sunscreen compounds have huge potential for use as next-generation photoprotection products.
    Sprache Englisch
    Erscheinungsdatum 2021-04-27
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms9050936
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Microfluidic arrays of dermal spheroids: a screening platform for active ingredients of skincare products.

    Chen, Zhengkun / Kheiri, Sina / Gevorkian, Albert / Young, Edmond W K / Andre, Valerie / Deisenroth, Ted / Kumacheva, Eugenia

    Lab on a chip

    2021  Band 21, Heft 20, Seite(n) 3952–3962

    Abstract: Organotypic micrometre-size 3D aggregates of skin cells (multicellular spheroids) have emerged as a ... ...

    Abstract Organotypic micrometre-size 3D aggregates of skin cells (multicellular spheroids) have emerged as a promising
    Mesh-Begriff(e) Animals ; Cell Culture Techniques ; Hydrogels ; Microfluidics ; Spheroids, Cellular
    Chemische Substanzen Hydrogels
    Sprache Englisch
    Erscheinungsdatum 2021-10-12
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2056646-3
    ISSN 1473-0189 ; 1473-0197
    ISSN (online) 1473-0189
    ISSN 1473-0197
    DOI 10.1039/d1lc00619c
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Buch ; Online: Cinquante nuances de rose. Les affinités électives du prince de Ligne

    Couvreur, Manuel / André, Valérie / Preyat, Fabrice / Speeckaert, Jean-Charles / Mouriau de Meulenacker, Pierre / Loir, Christophe / de Harlez de Deulin, Nathalie / Guri, Shipé / Colson, Bruno / Cornaz, Marie / Chaouche, Sabine::0000-0001-9467-3588::600 / Cerman, Ivo / Brix, Michel / Bernard, Bruno / Acke, Daniel

    2018  

    Abstract: Feld-maréchal, septième prince du nom, Charles-Joseph de Ligne (1735-1814) exerça une véritable fascination sur ses contemporains. Ce volume, auquel ont contribué des spécialistes issus de plusieurs disciplines, entend rompre avec la représentation figée ...

    Abstract Feld-maréchal, septième prince du nom, Charles-Joseph de Ligne (1735-1814) exerça une véritable fascination sur ses contemporains. Ce volume, auquel ont contribué des spécialistes issus de plusieurs disciplines, entend rompre avec la représentation figée dun homme et d'une œuvre trop longtemps méconnus
    Schlagwörter Literature (General) ; Ligne, Charles Joseph de
    Umfang 1 electronic resource (224 pages)
    Verlag Éditions de lUniversité de Bruxelles
    Dokumenttyp Buch ; Online
    Anmerkung French ; Open Access
    HBZ-ID HT020480817
    ISBN 9782800416298 ; 2800416297
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.

    Rastogi, Priya / O'Shaughnessy, Joyce / Martin, Miguel / Boyle, Frances / Cortes, Javier / Rugo, Hope S / Goetz, Matthew P / Hamilton, Erika P / Huang, Chiun-Sheng / Senkus, Elzbieta / Tryakin, Alexey / Cicin, Irfan / Testa, Laura / Neven, Patrick / Huober, Jens / Shao, Zhimin / Wei, Ran / André, Valérie / Munoz, Maria /
    San Antonio, Belen / Shahir, Ashwin / Harbeck, Nadia / Johnston, Stephen

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    2024  Band 42, Heft 9, Seite(n) 987–993

    Abstract: Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical trial ... ...

    Abstract Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical trial updates provide an opportunity to disseminate additional results from studies, published in
    Mesh-Begriff(e) Humans ; Female ; Breast Neoplasms/drug therapy ; Neoplasm Recurrence, Local ; Adjuvants, Immunologic ; Receptor, ErbB-2 ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aminopyridines ; Benzimidazoles
    Chemische Substanzen abemaciclib (60UAB198HK) ; ERBB2 protein, human (EC 2.7.10.1) ; Adjuvants, Immunologic ; Receptor, ErbB-2 (EC 2.7.10.1) ; Aminopyridines ; Benzimidazoles
    Sprache Englisch
    Erscheinungsdatum 2024-01-09
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 604914-x
    ISSN 1527-7755 ; 0732-183X
    ISSN (online) 1527-7755
    ISSN 0732-183X
    DOI 10.1200/JCO.23.01994
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang